mHealth Mozambique

GSK has partnered with telecoms giant Vodafone on a project that will see mobile technology employed to help increase childhood vaccination rates in Mozambique.

mVaccination Partnership

GSK has joined forces with Vodafone for an innovative partnership that aims to transform access to medicines and vaccines in developing countries by harnessing the power of mobile phone technology.

Despite major advances in the funding and availability of vaccines worldwide, up to one in five children still do not receive basic immunisation. The widespread availability of mobile phones in Africa offers an opportunity to create innovative and cost-effective solutions that address barriers to universal vaccination.

The initial focus of the new partnership is a one-year pilot vaccination project in Mozambique, in collaboration with the country’s Ministry of Health. This aims to establish if mobile technology solutions could increase the proportion of children covered by vaccination in Mozambique by an additional 5-10% in three key areas:

  • Mothers and caregivers will be registered on a Mozambique Ministry of Health database and alerted by SMS to the availability and importance of lifesaving vaccinations against common childhood diseases. Mothers will be able to schedule vaccination appointments by SMS, and receive notifications of past and future vaccinations, to ensure children complete the full schedule and become fully immunized;
  • Health workers will be provided with smart phones with software that allows them to contact mothers, view and record vaccination histories, schedule vaccinations and report on follow-up visits;
  • Healthcare facilities will be prompted to report regularly on crucial vaccination stock levels by SMS. This will enable critical supply chain management and ensure the availability of vaccines when and where they are needed, particularly in rural areas.

The pilot commenced in 2013 with 10 clinics, and will eventually include up to 100 clinics. It will be independently monitored by Harvard University to assess its impact, effectiveness and cost benefits. To ensure open access, the platform will be available to caregivers across any mobile network and can be used to increase take-up of any selected vaccine.

If successful, the project will create a model that can be replicated throughout Mozambique and eventually across Africa to reach thousands more children with life-saving vaccination.


  • GlaxoSmithKline (GSK)

    Goods Supplier
    United Kingdom | Staff size: 10,000+

    We are a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world,...

  • United States Agency for International Development (USAID)

    Funding Agencies
    United States | Staff size: Unknown

    USAID is the lead U.S. Government agency that works to end extreme global poverty and enable resilient, democratic societies to realize their potential.

    U.S. foreign assistance has...

  • Vodafone

    Service Providers
    United States | Staff size: Unknown

    Vodafone Group Plc is a British multinational telecommunications company headquartered in London, United Kingdom. It provides a wide range of services including voice, messaging, data and...

More Resources

Key Information

LocationMozambique, Southern Africa
  • Start Date 2014